keyword
https://read.qxmd.com/read/38652878/trans-ancestral-genetic-risk-factors-for-treatment-related-type-2-diabetes-mellitus-in-survivors-of-childhood-cancer
#1
JOURNAL ARTICLE
Cindy Im, Achal Neupane, Jessica L Baedke, Brian Lenny, Angela Delaney, Stephanie B Dixon, Eric J Chow, Sogol Mostoufi-Moab, Tianzhong Yang, Melissa A Richard, M Monica Gramatges, Philip J Lupo, Noha Sharafeldin, Smita Bhatia, Gregory T Armstrong, Melissa M Hudson, Kirsten K Ness, Leslie L Robison, Yutaka Yasui, Carmen L Wilson, Yadav Sapkota
PURPOSE: Type 2 diabetes mellitus (T2D) is a prevalent long-term complication of treatment in survivors of childhood cancer, with marked racial/ethnic differences in burden. In this study, we investigated trans-ancestral genetic risks for treatment-related T2D. PATIENTS AND METHODS: Leveraging whole-genome sequencing data from the St Jude Lifetime Cohort (N = 3,676, 304 clinically ascertained cases), we conducted ancestry-specific genome-wide association studies among survivors of African and European genetic ancestry (AFR and EUR, respectively) followed by trans-ancestry meta-analysis...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652812/genomic-profiling-to-contextualize-the-results-of-intervention-for-smoldering-multiple-myeloma
#2
JOURNAL ARTICLE
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis-Pistofidis, Bachisio Ziccheddu, Patrick Blaney, Monika Chojnacka, Michael Durante, Kylee Maclachlan, Ryan Young, Saad Usmani, Faith Davies, Gad Getz, Irene Ghobrial, Neha Korde, Gareth Morgan, Francesco Maura, Ola Landgren
PURPOSE: Early intervention for High-Risk Smoldering Multiple Myeloma (HR-SMM) achieves deep and prolonged responses. It is unclear if beneficial outcomes are due to treatment of less complex, susceptible disease or inaccuracy in clinical definition of cases entered. EXPERIMENTAL DESIGN: Here, we interrogated whole genome and whole exome sequencing for 54 patients across two HR-SMM interventional studies (NCT01572480, NCT02279394). RESULTS: We reveal that the genomic landscape of treated HR-SMM is generally simple as compared to Newly Diagnosed (ND)MM counterparts with less inactivation of tumor suppressor genes, RAS pathway mutations, MYC disruption, and APOBEC contribution...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652658/multiplexed-single-cell-lineage-tracing-of-mitotic-kinesin-inhibitor-resistance-in-glioblastoma
#3
JOURNAL ARTICLE
Yim Ling Cheng, Matei A Banu, Wenting Zhao, Steven S Rosenfeld, Peter Canoll, Peter A Sims
Glioblastoma (GBM) is a deadly brain tumor, and the kinesin motor KIF11 is an attractive therapeutic target with roles in proliferation and invasion. Resistance to KIF11 inhibitors, which has mainly been studied in animal models, presents significant challenges. We use lineage-tracing barcodes and single-cell RNA sequencing to analyze resistance in patient-derived GBM neurospheres treated with ispinesib, a potent KIF11 inhibitor. Similar to GBM progression in patients, untreated cells lose their neural lineage identity and become mesenchymal, which is associated with poor prognosis...
April 21, 2024: Cell Reports
https://read.qxmd.com/read/38652460/gastrointestinal-mucositis-a-sign-of-a-systemic-inflammatory-response
#4
JOURNAL ARTICLE
Nicole M A Blijlevens, Björn Reijnders, Eva Molendijk
PURPOSE OF REVIEW: Gastrointestinal mucositis (GIM) is a significant complication of cancer therapy. Whilst inflammation is a central feature of GIM, studies attempting to mitigate mucosal damage via this mechanism are scarce. This review describes the relation between GIM, local and systemic inflammation, and the microbiome and its metabolites, and explores recent research on therapeutics that target this relationship. RECENT FINDINGS: Recent literature underscores the pivotal role of inflammation in GIM, elucidating its bidirectional relation with disturbance of the gut microbiota composition and intestinal permeability...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652264/bacterial-discrimination-by-fourier-transform-infrared-spectroscopy-maldi-mass-spectrometry-and-whole-genome-sequencing
#5
JOURNAL ARTICLE
Rachel McGalliard, Howbeer Muhamadali, Najla AlMasoud, Sam Haldenby, Valeria Romero-Soriano, Ellie Allman, Yun Xu, Adam P Roberts, Steve Paterson, Enitan D Carrol, Royston Goodacre
Aim: Proof-of-concept study, highlighting the clinical diagnostic ability of FT-IR compared with MALDI-TOF MS, combined with WGS. Materials & methods: 104 pathogenic isolates of Neisseria meningitidis , Streptococcus pneumoniae , Streptococcus pyogenes and Staphylococcus aureus were analyzed. Results: Overall prediction accuracy was 99.6% in FT-IR and 95.8% in MALDI-TOF-MS. Analysis of N. meningitidis serogroups was superior in FT-IR compared with MALDI-TOF-MS. Phylogenetic relationship of S. pyogenes was similar by FT-IR and WGS, but not S...
April 23, 2024: Future Microbiology
https://read.qxmd.com/read/38652116/rapid-discrimination-of-four-salmonella-enterica-serovars-a-performance-comparison-between-benchtop-and-handheld-raman-spectrometers
#6
COMPARATIVE STUDY
Quan Yuan, Bin Gu, Wei Liu, Xin-Ru Wen, Ji-Liang Wang, Jia-Wei Tang, Muhammad Usman, Su-Ling Liu, Yu-Rong Tang, Liang Wang
Foodborne illnesses, particularly those caused by Salmonella enterica with its extensive array of over 2600 serovars, present a significant public health challenge. Therefore, prompt and precise identification of S. enterica serovars is essential for clinical relevance, which facilitates the understanding of S. enterica transmission routes and the determination of outbreak sources. Classical serotyping methods via molecular subtyping and genomic markers currently suffer from various limitations, such as labour intensiveness, time consumption, etc...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38651937/molecular-classification-and-intratumoral-heterogeneity-of-gastric-adenocarcinoma
#7
REVIEW
Takeshi Kuwata
Gastric cancers frequently harbor striking histological complexity and diversity between lesions as well as within single lesions, known as inter- and intratumoral heterogeneity, respectively. The latest World Health Organization Classification of Tumors designated more than 30 histological subtypes for gastric epithelial tumors, assigning 12 subtypes for gastric adenocarcinoma (GAD). Meanwhile, recent advances in genome-wide analyses have provided molecular aspects to the histological classification of GAD, and consequently revealed different molecular traits underlying these histological subtypes...
April 23, 2024: Pathology International
https://read.qxmd.com/read/38651885/first-report-of-the-chromosomal-integration-of-carbapenemase-gene-bla-imp-19-in-acinetobacter-baumannii-ab322-the-legacy-of-integron-in-phage-plasmid
#8
JOURNAL ARTICLE
Yung-Luen Shih, Carl Jay Ballena Bregente, Pek Kee Chen, Tran Thi Dieu Thuy, Yu-Chen Chen, Han-Yueh Kuo, Hsu-Feng Lu, Cheng-Yen Kao
UNLABELLED: Integration of carbapenemase gene bla IMP into the chromosome of carbapenem-resistant Acinetobacter baumannii (CRAB) has not been reported. The aim of this study was to explore the genomic characteristics of CRAB AB322 isolated from a Taiwanese patient diagnosed with bacteremia in 2011, whose chromosome harbors bla IMP-19 . Disk diffusion and broth microdilution were employed to analyze the antimicrobial susceptibility of AB322 to 14 antimicrobials. Nanopore whole-genome sequencing platform was utilized for AB322 genome sequencing, and conjugation was further performed to investigate the transferability of bla IMP-19 to amikacin-resistant A...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651881/coliseq-a-multiplex-amplicon-assay-that-provides-strain-level-resolution-of-escherichia-coli-directly-from-clinical-specimens
#9
JOURNAL ARTICLE
Charles H D Williamson, Adam J Vazquez, Amalee E Nunnally, Kristen Kyger, Viacheslav Y Fofanov, Tara N Furstenau, Heidie M Hornstra, Joel Terriquez, Paul Keim, Jason W Sahl
Escherichia coli is a diverse pathogen, causing a range of disease in humans, from self-limiting diarrhea to urinary tract infections (UTIs). Uropathogenic E. coli (UPEC) is the most frequently observed uropathogen in UTIs, a common disease in high-income countries, incurring billions of dollars yearly in treatment costs. Although E. coli is easily grown and identified in the clinical laboratory, genotyping the pathogen is more complicated, yet critical for reducing the incidence of disease. These goals can be achieved through whole-genome sequencing of E...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651877/detection-of-mtb-and-ntm-preclinical-validation-of-a-new-asymmetric-pcr-binary-deoxyribozyme-sensor-assay
#10
JOURNAL ARTICLE
Yasmin Castillos das Neves, Ana Julia Reis, Marcos Alaniz Rodrigues, Erica Chimara, Maria Cristina da Silva Lourenço, Jacques Fountain, Ivy Bastos Ramis, Andrea von Groll, Yulia Gerasimova, Kyle H Rohde, Pedro Eduardo Almeida da Silva
Tuberculosis (TB) and infectious diseases caused by non-tuberculous mycobacteria (NTM) are global concerns. The development of a rapid and accurate diagnostic method, capable of detecting and identifying different mycobacteria species, is crucial. We propose a molecular approach, the BiDz-TB/NTM, based on the use of binary deoxyribozyme (BiDz) sensors for the detection of Mycobacterium tuberculosis (Mtb) and NTM of clinical interest. A panel of DNA samples was used to evaluate Mtb-BiDz, Mycobacterium abscessus / Mycobacterium chelonae -BiDz, Mycobacterium avium -BiDz, Mycobacterium intracellulare / Mycobacterium chimaera -BiDz, and Mycobacterium kansasii -BiDz sensors in terms of specificity, sensitivity, accuracy, and limit of detection...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651398/an-opportunity-to-fill-a-gap-for-newborn-screening-of-neurodevelopmental-disorders
#11
JOURNAL ARTICLE
Wendy K Chung, Stephen M Kanne, Zhanzhi Hu
Screening newborns using genome sequencing is being explored due to its potential to expand the list of conditions that can be screened. Previously, we proposed the need for large-scale pilot studies to assess the feasibility of screening highly penetrant genetic neurodevelopmental disorders. Here, we discuss the initial experience from the GUARDIAN study and the systemic gaps in clinical services that were identified in the early stages of the pilot study.
April 16, 2024: International Journal of Neonatal Screening
https://read.qxmd.com/read/38651395/newborn-screening-today-and-tomorrow-a-brief-report-from-the-international-primary-immunodeficiencies-congress
#12
Leire Solis, Samya Van Coillie, James R Bonham, Fabian Hauck, Lennart Hammarström, Frank J T Staal, Bruce Lim, Martine Pergent, Johan Prévot
This article presents the report of the session on "Newborn Screening for Primary Immunodeficiencies-Now What?" organised during the International Primary Immunodeficiency Congress (IPIC) held in November 2023. This clinical conference was organised by the International Patient Organisation for Primary Immunodeficiencies (IPOPI), the global patient organisation advocating for primary immunodeficiencies (PIDs) in patients. The session aimed at exploring the advances in newborn screening (NBS) for severe combined immunodeficiency, starting with the common practice and inserting the discussion into the wider perspective of genomics whilst taking into consideration the ethical aspects of screening as well as incorporating families and the public into the discussions, so as to ensure that NBS for treatable rare disorders continues to be one of the major public health advances of the 20th century...
April 5, 2024: International Journal of Neonatal Screening
https://read.qxmd.com/read/38651248/genomic-testing-identifies-monogenic-causes-in-patients-with-very-early-onset-inflammatory-bowel-disease-a-multi-center-survey-in-an-iranian-cohort
#13
JOURNAL ARTICLE
Golnaz Eslamian, Mahnaz Jamee, Tooba Momen, Pejman Rohani, Sarehossadat Ebrahimi, Mehrnaz Mesdaghi, Soodeh Ghadimi, Mahboubeh Mansouri, Seyed Alireza Mahdaviani, Mahnaz Sadeghi-Shabestari, Morteza Fallahpour, Bibi Shahin Shamsian, Narges Eslami, Samin Sharafian, Naghi Dara, Peiman Nasri, Niloufar Amini, Javad Enayat, Mazdak Fallahi, Leila Ghasemi Hashtrodi, Mohammad Shojaei, Martha Guevara Becerra, Holm H Uhlig, Zahra Chavoshzadeh
Patients with very early-onset inflammatory bowel disease (VEO-IBD) may present because of underlying monogenic inborn errors of immunity (IEI). Strong differences have been observed in the causes of monogenic IBD among ethnic populations. This multi-center study was carried out on 16 Iranian patients with VEO-IBD. We reviewed clinical and basic immunologic evaluation including flow cytometry and immunoglobulin levels. All patients underwent clinical whole exome sequencing (WES). Sixteen patients (8 females and 8 males) with a median age of 43...
April 23, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38651154/case-report-salivary-duct-carcinoma-in-a-patient-with-a-germline-cdh1-pathogenic-variant-expanding-the-spectrum-of-hereditary-cancer-predisposition-syndromes
#14
Nidhi Desai, Emilian Racila, Naomi Fujioka, Arjun Gupta, Emmanuel S Antonarakis
INTRODUCTION: Recently, an entity known as salivary duct carcinoma with rhabdoid features (SDC-RF) has been associated with somatic CDH1 mutations. Here we present the first known case report of conventional SDC occurring in the setting of a germline CDH1 pathogenic variant accompanied by a somatic loss of heterozygosity at the CDH1 locus. CASE DISCUSSION: A 67-year-old man presented with chest and back pain and was found to have osteolytic lesions in the sternum and lumbar spine...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651072/downregulation-of-nat1-expression-is-associated-with-poor-prognosis-and-immune-infiltration-in-coad
#15
JOURNAL ARTICLE
Houxi Xu, Hongqun Zhang, Songxian Sun, Jingyuan Zhang, Jiege Huo, Chunxiang Zhou
BACKGROUND: An increasing corpus of evidence has identified the involvement of N-acetyltransferase 1 (NAT1), a member of the NAT family, in the progression of various cancers. However, the specific function of NAT1 in colon cancer (COAD) remains elusive. This study aims to decip her the role of NAT1 in COAD and its associated mechanisms. METHODS: The Tumor Immunity Evaluation Resource (TIMER), The Cancer Genome Atlas (TCGA), and the Gene Expression Omnibus (GEO) databases were employed to assess the NAT1 expression level in COAD...
2024: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/38650747/genetic-and-multi-omic-risk-assessment-of-alzheimer-s-disease-implicates-core-associated-biological-domains
#16
JOURNAL ARTICLE
Gregory A Cary, Jesse C Wiley, Jake Gockley, Stephen Keegan, Sai Sruthi Amirtha Ganesh, Laura Heath, Robert R Butler, Lara M Mangravite, Benjamin A Logsdon, Frank M Longo, Allan Levey, Anna K Greenwood, Gregory W Carter
INTRODUCTION: Alzheimer's disease (AD) is the predominant dementia globally, with heterogeneous presentation and penetrance of clinical symptoms, variable presence of mixed pathologies, potential disease subtypes, and numerous associated endophenotypes. Beyond the difficulty of designing treatments that address the core pathological characteristics of the disease, therapeutic development is challenged by the uncertainty of which endophenotypic areas and specific targets implicated by those endophenotypes to prioritize for further translational research...
2024: Alzheimer's & Dementia: Translational Research & Clinical Interventions
https://read.qxmd.com/read/38650309/leveraging-dna-methylation-to-predict-treatment-response-in-major-depressive-disorder-a-critical-review
#17
REVIEW
Jan Dahrendorff, Glenn Currier, Monica Uddin
Major depressive disorder (MDD) is a debilitating and prevalent mental disorder with a high disease burden. Despite a wide array of different treatment options, many patients do not respond to initial treatment attempts. Selection of the most appropriate treatment remains a significant clinical challenge in psychiatry, highlighting the need for the development of biomarkers with predictive utility. Recently, the epigenetic modification DNA methylation (DNAm) has emerged to be of great interest as a potential predictor of MDD treatment outcomes...
April 22, 2024: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
https://read.qxmd.com/read/38650144/comprehensive-bioinformatics-analysis-of-kif20a-as-a-prognosis-biomarker-for-clear-cell-renal-cell-carcinoma
#18
JOURNAL ARTICLE
Cankun Xie, Wingkeung Yiu, Yijiang Mo
It has been shown that kinesin family member 20A (KIF20A) is involved in the development of several cancers. However, research on clear cell renal cell carcinoma (ccRCC) and KIF20A is still exploratory. The current research was carried out to determine whether KIF20A expression has any prognosis value in ccRCC. Data were downloaded from The Cancer Genome Atlas (TCGA) database to validate the KIF20A mRNA expression and to perform clinicopathological analysis. Receiver operating characteristic (ROC) curves were used in evaluating KIF20A's diagnostic performance for ccRCC...
March 31, 2024: Cellular and Molecular Biology
https://read.qxmd.com/read/38650040/clinical-pathologic-and-genomic-characteristics-of-two-pediatric-glioneuronal-tumors-with-a-clip2-met-fusion
#19
JOURNAL ARTICLE
Nicholas Chapman, Joshua Greenwald, Jolee Suddock, Dong Xu, Alexander Markowitz, Maeve Humphrey, Jennifer A Cotter, Mark D Krieger, Debra Hawes, Jianling Ji
Integration of molecular data with histologic, radiologic, and clinical features is imperative for accurate diagnosis of pediatric central nervous system (CNS) tumors. Whole transcriptome RNA sequencing (RNAseq), a genome-wide and non-targeted approach, allows for the detection of novel or rare oncogenic fusion events that contribute to the tumorigenesis of a substantial portion of pediatric low- and high-grade glial and glioneuronal tumors. We present two cases of pediatric glioneuronal tumors occurring in the occipital region with a CLIP2::MET fusion detected by RNAseq...
April 22, 2024: Acta Neuropathologica Communications
https://read.qxmd.com/read/38650020/meta-analysis-of-the-global-distribution-of-clinically-relevant-cyp2c8-alleles-and-their-inferred-functional-consequences
#20
JOURNAL ARTICLE
Mahamadou D Camara, Yitian Zhou, Taís Nóbrega De Sousa, José P Gil, Abdoulaye A Djimde, Volker M Lauschke
BACKGROUND: CYP2C8 is responsible for the metabolism of 5% of clinically prescribed drugs, including antimalarials, anti-cancer and anti-inflammatory drugs. Genetic variability is an important factor that influences CYP2C8 activity and modulates the pharmacokinetics, efficacy and safety of its substrates. RESULTS: We profiled the genetic landscape of CYP2C8 variability using data from 96 original studies and data repositories that included a total of 33,185 unrelated participants across 44 countries and 43 ethnic groups...
April 22, 2024: Human Genomics
keyword
keyword
28768
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.